SEC Form 4 · accession 0001645627-18-000037
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jul 9, 2018
Accepted (ET)
Jul 17, 2018 · 12:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 9, 2018 | P | 1,000 | $0.0376 | A | 25,175,289 | D | |
| Common Stock | Jul 10, 2018 | P | 1,000 | $0.0367 | A | 25,176,289 | D | |
| Common Stock | Jul 10, 2018 | P | 1,000 | $0.0367 | A | 25,177,289 | D | |
| Common Stock | Jul 11, 2018 | P | 1,000 | $0.037 | A | 25,178,289 | D | |
| Common Stock | Jul 11, 2018 | P | 1,000 | $0.0361 | A | 25,179,289 | D | |
| Common Stock | Jul 11, 2018 | P | 1,000 | $0.0342 | A | 25,180,289 | D | |
| Common Stock | Jul 13, 2018 | P | 1,000 | $0.0349 | A | 25,181,289 | D | |
| Common Stock | Jul 13, 2018 | P | 1,000 | $0.0349 | A | 25,182,289 | D |
Table II — derivative securities
No Table II lines on this filing.